Literature DB >> 21041349

Recovery from disability for individuals with borderline personality disorder: a feasibility trial of DBT-ACES.

Katherine Anne Comtois1, Amanda Holland Kerbrat, David C Atkins, Melanie S Harned, Lynn Elwood.   

Abstract

OBJECTIVES: Employment and recovery can be difficult goals to reach for individuals with severe borderline personality disorder, even for those who have successfully completed dialectical behavior therapy (DBT) and are no longer in crisis. This study examined the feasibility of DBT-Accepting the Challenges of Exiting the System (DBT-ACES), a follow-up to standard DBT (SDBT).
METHODS: A pre-post evaluation was conducted of the outcomes for 30 clients with borderline personality disorder who entered DBT-ACES during the study period (April 2000 to June 2005). Outcomes included employment, exit from the public mental health system, and quality of life, as well as self-inflicted injury and emergency and inpatient admissions.
RESULTS: From the end of SDBT to the end of DBT-ACES, the study found a significant improvement in participants' odds of being employed or in school (odds ratio [OR]=3.34, p<.05), working at least 20 hours per week (OR=4.93, p=.01), and subjective quality of life (B=.49, p=.03) and a decrease in the number of inpatient admissions (RR=.07, p<.05). Comparing the end of SDBT to a year after DBT-ACES, the latter two outcomes were mostly retained, but the findings were not significant. One year after leaving DBT-ACES, only 36% of DBT-ACES clients were still receiving public mental health services. Emergency room admissions, inpatient psychiatry admissions, and medically treated self-inflicted injuries all decreased during SDBT and remained low during and following DBT-ACES.
CONCLUSIONS: This study demonstrated the feasibility of meaningful recovery from severe borderline personality disorder with a combination of SDBT and DBT-ACES, but controlled research is needed.

Entities:  

Mesh:

Year:  2010        PMID: 21041349     DOI: 10.1176/ps.2010.61.11.1106

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  8 in total

Review 1.  Psychotherapy for Borderline Personality Disorder: Progress and Remaining Challenges.

Authors:  Paul S Links; Ravi Shah; Rahel Eynan
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

2.  The connections place: a job preparedness program for individuals with borderline personality disorder.

Authors:  Beth Elliott; Richard J Konet
Journal:  Community Ment Health J       Date:  2013-02-14

3.  Probable Post-traumatic Stress Disorder and Self-harming Behaviour: Potential Barriers to Employment?

Authors:  J S Hansen; E Simonsen
Journal:  Community Ment Health J       Date:  2017-11-14

4.  Improving functional outcomes in women with borderline personality disorder and PTSD by changing PTSD severity and post-traumatic cognitions.

Authors:  Melanie S Harned; Chelsey R Wilks; Sara C Schmidt; Trevor N Coyle
Journal:  Behav Res Ther       Date:  2018-02-06

5.  Employment in borderline personality disorder.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2012-09

6.  Using Measurement-Based Care to Enhance Any Treatment.

Authors:  Kelli Scott; Cara C Lewis
Journal:  Cogn Behav Pract       Date:  2015-02

7.  Predicting dropout in outpatient dialectical behavior therapy with patients with borderline personality disorder receiving psychiatric disability.

Authors:  Sara J Landes; Samantha A Chalker; Katherine Anne Comtois
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2016-09-01

Review 8.  Current state of the evidence on community treatments for people with complex emotional needs: a scoping review.

Authors:  Sarah Ledden; Luke Sheridan Rains; Merle Schlief; Phoebe Barnett; Brian Chi Fung Ching; Brendan Hallam; Mia Maria Günak; Thomas Steare; Jennie Parker; Sarah Labovitch; Sian Oram; Steve Pilling; Sonia Johnson
Journal:  BMC Psychiatry       Date:  2022-09-05       Impact factor: 4.144

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.